HLB Pharmaceutical

047920 · KOSDAQ · ₩047920 · HLB제약

₩9,890▲ ₩160 (1.64%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩206B₩137B₩136B₩107B₩63B
Cost of sales₩99B₩51B₩53B₩43B₩27B
Gross profit₩107B₩87B₩83B₩64B₩35B
Operating income₩1.1B₩1.5B−₩20B−₩6.4B₩486M
Net income₩4.6B₩2B−₩19B−₩12B−₩13B
Net income to shareholders₩4.6B₩2B−₩19B−₩12B−₩13B

Balance sheet

20252024202320222021
Total assets₩171B₩158B₩141B₩142B₩128B
Current assets₩77B₩63B₩72B₩60B₩51B
Cash and equivalents₩7.6B₩10B₩4.8B₩9.7B₩6.6B
Total liabilities₩46B₩42B₩53B₩56B₩49B
Current liabilities₩40B₩39B₩49B₩53B₩46B
Borrowings₩15B₩15B₩22B₩24B₩30B
Total equity₩125B₩116B₩88B₩86B₩78B
Shareholders' equity₩125B₩116B₩88B₩86B₩78B

Cash flow

20252024202320222021
Cash from operations₩569M₩6.8B−₩18B−₩2.8B−₩1.3B
Capital spending₩7.2B₩2.8B₩2.7B₩2.7B₩49B
Free cash flow−₩6.6B₩4B−₩21B−₩5.5B−₩51B

Consolidated where available. Amounts in won.

Also known as: HLB Pharmaceutical / HLB제약 / 047920 / KRX:047920

Source: KRX statistical information